312 related articles for article (PubMed ID: 14636317)
1. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM
Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam.
Krupp E; Heynen T; Li XL; Post RM; Weiss SR
Exp Neurol; 2000 Apr; 162(2):278-89. PubMed ID: 10739634
[TBL] [Abstract][Full Text] [Related]
3. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model.
Vinogradova LV; van Rijn CM
Epilepsia; 2008 Jul; 49(7):1160-8. PubMed ID: 18397292
[TBL] [Abstract][Full Text] [Related]
5. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam.
Löscher W; Hönack D
Epilepsia; 2000 Dec; 41(12):1499-506. PubMed ID: 11114206
[TBL] [Abstract][Full Text] [Related]
6. The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats.
Gu J; Lynch BA; Anderson D; Klitgaard H; Lu S; Elashoff M; Ebert U; Potschka H; Löscher W
Eur J Neurosci; 2004 Jan; 19(2):334-45. PubMed ID: 14725628
[TBL] [Abstract][Full Text] [Related]
7. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.
Wu T; Ido K; Ohgoh M; Hanada T
Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244
[TBL] [Abstract][Full Text] [Related]
8. Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine.
Weiss SR; Post RM
Epilepsia; 1991; 32(1):140-5. PubMed ID: 1985824
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
Löscher W; Hönack D; Rundfeldt C
J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.
Srivastava AK; White HS
Epilepsy Res; 2013 Mar; 104(1-2):26-34. PubMed ID: 23158096
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
13. Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: increase in anticonvulsant but decrease in adverse effect potential.
Löscher W; Fiedler M
Epilepsia; 2000 May; 41(5):516-28. PubMed ID: 10802756
[TBL] [Abstract][Full Text] [Related]
14. Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.
Stratton SC; Large CH; Cox B; Davies G; Hagan RM
Epilepsy Res; 2003 Feb; 53(1-2):95-106. PubMed ID: 12576171
[TBL] [Abstract][Full Text] [Related]
15. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ
Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462
[TBL] [Abstract][Full Text] [Related]
16. The benzodiazepine partial inverse agonist Ro15-4513 alters anticonvulsant and lethal effects of carbamazepine in amygdala-kindled rats.
Zhang ZJ; Postma T; Obeng K; Russell S; Weiss SR; Post RM
Neurosci Lett; 2002 Sep; 329(3):253-6. PubMed ID: 12183024
[TBL] [Abstract][Full Text] [Related]
17. Rapid kindling in preclinical anti-epileptic drug development: the effect of levetiracetam.
De Smedt T; Vonck K; Raedt R; Dedeurwaerdere S; Claeys P; Legros B; Wyckhuys T; Wadman W; Boon P
Epilepsy Res; 2005 Dec; 67(3):109-16. PubMed ID: 16289683
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.
Postma T; Krupp E; Li XL; Post RM; Weiss SR
Epilepsia; 2000 Dec; 41(12):1514-21. PubMed ID: 11114208
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model.
Ohno Y; Ishihara S; Terada R; Serikawa T; Sasa M
Epilepsy Res; 2010 May; 89(2-3):360-4. PubMed ID: 20138737
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
